Abstract
With rapid progress in nanomedicine, magnetic nanoparticles (MNPs) have been proved as a promising theranostics tool in biomedical applications including diagnostic imaging, drug delivery, and novel therapeutics. Multiple myeloma is a hematological malignancy with relapse rate greater than 90%. Limitations in the treatment of MM are the serious side effects caused by drugs used in chemotherapy. The emphasis in cancer treatment has shifted from cytotoxic, non-specific chemotherapies to molecularly targeted and rationally designed therapies showing greater efficacy with fewer side effects. Nanomedicine may help to address these issues and a revolutionary treatment. Here, we explained brief insights of MM, the key pathways that play a vital role in the development of the disease and the role of magnetic nanoparticles in the diagnosis and treatment of the MM.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
